Galectin-9 (encoded by LGALS9), as the most studied ligand for HAVCR2, is specifically expressed by NPC cells, as an immunosuppressive molecule induced by high intratumoral IFN-β and IFN-γ (58, 59). Here, HAVCR2 is linked to nasopharyngeal carcinoma.